This is a procurement-oriented overview for distributors, hospitals, and clinics evaluating deep vein thrombosis (dvt) devices. Left untreated, extensive iliofemoral DVT is associated with a higher risk of long-term complications such as post-thrombotic syndrome, marked by chronic swelling and discomfort. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Deep Vein Thrombosis (DVT)
Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. Whether an interventional approach is appropriate is a clinical decision that weighs clot age, location, bleeding risk, and overall condition. Techniques include mechanical thrombectomy, aspiration thrombectomy, and pharmacomechanical approaches that combine device action with a clot-dissolving drug.
Regulatory Status and Manufacturing
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Portfolio and Sizing
Within this category, INVAMED lists devices such as Mantis PRO Rotational Thrombectomy & Ultra Aspiration, Mantis Directional Thrombectomy System, Mantis CURVE Over-the-Wire, Mantis AspireJET Thrombectomy System, Mantis XP Thrombectomy System for Fistula, MultiBEAM Inferior Vena Cava, Viper ULTRA Thrombolysis Catheter, Dovi Thrombus Ultra Aspiration Catheter. Size ranges, materials, and configurations are detailed in product documentation and the applicable IFU.
Key Considerations
- Retrievable IVC filters are intended to be removed once protection is no longer needed, per current guidance.
- Manufacturer performance descriptions reflect device design goals rather than guaranteed individual outcomes.
- All INVAMED thrombectomy devices are for use by trained interventionalists under imaging guidance and per the IFU.
Frequently Asked Questions
Is the MultiBEAM IVC filter retrievable?
Yes. INVAMED describes MultiBEAM as a retrievable IVC filter, designed to be removed once the risk of pulmonary embolism has passed.
Does thrombectomy replace blood thinners?
No. Catheter thrombectomy removes existing clot but is generally used alongside anticoagulation, not as a replacement; management is individualized.
Who is a candidate for catheter-based clot removal?
Candidacy is a clinical decision based on clot extent, location, symptoms, and bleeding risk; this content is educational only.
About INVAMED
INVAMED states it holds more than 100 international patents across its device portfolio. INVAMED operates a dedicated R&D center (INVAcenter) focused on minimally invasive device development.
Clinical and Technical Context
Rotational energy is applied under imaging guidance to protect the vein wall. Device choice within a mechanical approach depends on clot location, chronicity, and vessel size. Whether an interventional approach is appropriate is a clinical decision that weighs clot age, location, bleeding risk, and overall condition. Manufacturer performance descriptions reflect device design goals rather than guaranteed individual outcomes. Access salvage decisions are made by the vascular access team based on the specific circuit. INVAMED's Mantis PRO and Mantis CURVE incorporate rotational action within the Mantis family. All INVAMED thrombectomy devices are for use by trained interventionalists under imaging guidance and per the IFU. Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. Left untreated, extensive iliofemoral DVT is associated with a higher risk of long-term complications such as post-thrombotic syndrome, marked by chronic swelling and discomfort. Use of any thrombolytic is governed by bleeding-risk assessment performed by the clinician. INVAMED's Viper ULTRA thrombolysis catheter is designed for this localized infusion role. Endovascular thrombus removal aims to restore venous flow quickly and, in appropriate cases, to reduce the risk of post-thrombotic syndrome.
Related on INVAMED
- Deep Vein Thrombosis (DVT) — product category
- Comparing Mechanical thrombectomy and Thrombolysis alone
- MultiBEAM Inferior Vena Cava (IVC) Filter — Technical Overview
- Viper ULTRA Thrombolysis Catheter — Technical Overview
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.